The consumer champion is now calling on the government to introduce a mandatory front-of-pack nutrition labelling scheme. It ...

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

Drugs like Ozempic have transformed how we treat obesity, but a review of almost 40 studies shows it doesn't take long for ...

The health-care corner of the US equity market has traditionally been viewed as defensive, thanks to steady growth and healthy dividend yields among the industry’s stalwarts. That narrative is ...

Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...

A new definition of obesity could nearly double the prevalence of U.S. adults with the condition, a new study published ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 ...

Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as ...

Arrowhead Pharmaceuticals has reported early-phase data on a pair of gene silencing drug candidates in obesity, posting ...

Both the new weight loss drugs and bariatric (weight loss) surgery improve body composition in patients with obesity by ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.